JUHI GOR: Open Payments
NPI 1447899471 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $252 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $153 |
| Amgen Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $115 |
| Edwards Lifesciences Corporation | 1 | $50 |
| Novartis Pharmaceuticals Corporation | 1 | $38 |
| United Therapeutics Corporation | 1 | $25 |
Products named: CARDIOMEMS, REPATHA, LIVTENCITY, LifeVest, PASCAL, LEQVIO, TYVASO.
Industry payments across TX — which companies pay providers there.
